Eli Lilly’s stock price has underperformed this year, much of it on the back of drug pricing concerns, potential tariff impacts and, perhaps, less enthusiasm for GLP-1 drugs. The primary drag for the ...

During the third quarter of 2025, the Patient Opportunity Equity Strategy generated a total return of 14.1% net of fees. Relative to the index, the strategy was overweight the Consumer Discretionary, ...

BOISE, Idaho & CHICAGO & NEW YORK & LONDON--(BUSINESS WIRE)--Clearwater Analytics (NYSE: CWAN), the most comprehensive technology platform for investment management, today announced that HG Re Ltd.

Dublin, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The "Investment Performance Measurement, Risk & Attribution (Mar 23rd - Mar 25th, 2026)" training has been added to ResearchAndMarkets.com's offering. This is ...

MSCI’s multi-asset class performance analytics models enable measurement, attribution, and appraisal of portfolio performance. Portfolio managers need actionable insights that explain their portfolios ...

FactSet’s Performance Solution (FPS) supports official performance, attribution, Global Investment Performance Standards (GIPS) reporting and risk analysis. The software-as-a-service (SaaS)-based ...

The inaugural solution aims to address demand for accurate and real-time performance analytics, helping investment managers examine the effectiveness of their investment strategies. SimCorp has ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...